Track the Ambrx Biopharma Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 19 September 2023 (Acquisition). Among the most active insiders: Cormorant Asset Management, LP. Every trade is accessible without an account.
12
Insider Decl.
n/a
Thresholds
€65m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
Buys €65mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
250,000 shares@ US$9.95313.6% of flowOrdinary SharesSEC:0000929638-23-000867:0
Canonical exit: 12 Jun 2023 (T+90)
12 of 12 declarations
About Ambrx Biopharma Inc.
Ambrx Biopharma Inc. is a biopharmaceutical company focused on developing therapies based on recombinant proteins. It utilizes innovative technology to design drugs targeting serious diseases.